Qube Research & Technologies LTD Puma Biotechnology, Inc. Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 204,222 shares of PBYI stock, worth $616,750. This represents 0.0% of its overall portfolio holdings.
Number of Shares
204,222
Previous 273,158
25.24%
Holding current value
$616,750
Previous $890,000
41.57%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding PBYI
# of Institutions
101Shares Held
29MCall Options Held
50.6KPut Options Held
16.3K-
Vanguard Group Inc Valley Forge, PA3.64MShares$11 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$10.8 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.06MShares$9.25 Million0.42% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.88MShares$8.7 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.97MShares$5.95 Million0.02% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $138M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...